ECS Botanics Holdings (ASX:ECS) Net Margin %: -7.35% (As of Dec. 2025)

What is ECS Botanics Holdings Net Margin %?

ECS Botanics Holdings ASX:ECS -11.11% Net Margin % is -7.35% as of Dec. 2025. The stock has 9 warning signs investors should review. Among 956 Drug Manufacturers companies, ECS Botanics Holdings ranks worse than 82.43% on this metric.

Net margin is calculated as Net Income divided by its Revenue. ECS Botanics Holdings's Net Income for the six months ended in Dec. 2025 was A$-0.83 Mil. ECS Botanics Holdings's Revenue for the six months ended in Dec. 2025 was A$11.34 Mil. Therefore, ECS Botanics Holdings's net margin for the quarter that ended in Dec. 2025 was -7.35%.

The historical rank and industry rank for ECS Botanics Holdings's Net Margin % or its related term are showing as below:

ASX:ECS' s Net Margin % Range Over the Past 10 Years
Min: -545.88 Med: -29.61 Max: 9.94
Current: -21.87

ASX:ECS's Net Margin % is ranked worse than
82.43% of 956 companies
in the Drug Manufacturers industry
Industry Median: 5.56 vs ASX:ECS: -21.87

ECS Botanics Holdings (ASX:ECS) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

ECS Botanics Holdings Net Margin % Related Terms

ECS Botanics Holdings Net Margin % Historical Data

* Premium members only.

The historical data trend for ECS Botanics Holdings's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ECS Botanics Holdings Net Margin % Chart

ECS Botanics Holdings Annual Data

Trend

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Jun25

Net Margin %

Get a 7-Day Free Trial

-347.71

-16.96

-0.53

9.94

-29.61

ECS Botanics Holdings Semi-Annual Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24	Jun25	Dec25
Net Margin %	Get a 7-Day Free Trial															11.06	8.48	-20.34	-38.98	-7.35

ASX:ECS vs ZTS: Net Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, ECS Botanics Holdings's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ECS Botanics Holdings Net Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, ECS Botanics Holdings's Net Margin % distribution charts can be found below:

* The bar in red indicates where ECS Botanics Holdings's Net Margin % falls into.

Save Embed

ECS Botanics Holdings Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

ECS Botanics Holdings's Net Margin for the fiscal year that ended in Jun. 2025 is calculated as

Net Margin	=	Net Income (A: Jun. 2025 )	/	Revenue (A: Jun. 2025 )
	=	-5.733	/	19.363
	=	-29.61 %

ECS Botanics Holdings's Net Margin for the quarter that ended in Dec. 2025 is calculated as

Net Margin	=	Net Income (Q: Dec. 2025 )	/	Revenue (Q: Dec. 2025 )
	=	-0.834	/	11.342
	=	-7.35 %

Frequently Asked Questions Learn more about Net Margin % →

What does a Net Margin % of -7.35% mean?

ECS Botanics Holdings (ASX:ECS) has a Net Margin % of -7.35% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on ECS Botanics Holdings and its competitors. According to the industry distribution chart, ECS Botanics Holdings ranks #788 out of 956 companies in the Drug Manufacturers industry, placing it in the top 82.4%.

Is ECS Botanics Holdings' Net Margin % too high?

ECS Botanics Holdings' current Net Margin % is -7.35%. Based on the distribution chart, ECS Botanics Holdings ranks #788 out of 956 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.

How does ECS Botanics Holdings' Net Margin % compare to ZTS?

According to the Drug Manufacturers industry distribution chart, ECS Botanics Holdings ranks #788 out of 956 companies for Net Margin %. This places ECS Botanics Holdings in the lower half of its industry. The industry median Net Margin % is 5.56. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Net Margin % for a Drug Manufacturers company?

The median Net Margin % among Drug Manufacturers companies is 5.56, based on 956 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Net Margin % mean?

A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on ECS Botanics Holdings and its competitors. For the Drug Manufacturers industry, the median Net Margin % is 5.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ECS Botanics Holdings's current Net Margin % is -7.35%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is ECS Botanics Holdings stock overvalued right now?

Based on GuruFocus' analysis, ECS Botanics Holdings (ASX:ECS) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.02, compared to a current price of A$0.00 — trading 80% below its estimated fair value. The current Net Margin % is -7.35%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Net Margin % calculated?

Net Margin % is calculated from a company's financial statements. For ECS Botanics Holdings (ASX:ECS), the current Net Margin % is -7.35% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

ECS Botanics Holdings Business Description

Industry Healthcare Drug Manufacturers

Comparable Companies ASX:PER ASX:EPN ASX:CAN ASX:BP8 ASX:RGT ASX:IVX ASX:EXL ASX:IDT ASX:PKP ASX:VIT XTER:MRK TSE:4502 XSWX:GALD SHSE:600276 NSE:SUNPHARMA XTAE:TEVA LSE:HLN XSWX:SDZ ZTS HKSE:03692

Address 899 River Road, Murrabit West, Murrabit, VIC, AUS, 3579

Website https://www.ecs-botanics.com

ECS Botanics Holdings Ltd is an Australian medicinal cannabis cultivator and manufacturer located in Northwest Victoria. The company utilizes progressive cultivation methodologies to produce quality medicine in a sustainable way, adopting regenerative and organic horticultural practices and renewable energy sources. Licensed by the Therapeutic Drug Administration to manufacture PIC/S GMP certified products, the company provides quality, affordable medicinal cannabis, supplying both local and overseas markets.